LSPN 19: Courts need to revisit patentability of diagnostic tests

Life Sciences Intellectual Property Review | April 26, 2019 — US courts need to revisit the patentability of diagnostic tests under section 101, according to Memorial Sloan Kettering Cancer Center’s chief IP counsel.

Click to read the full article at lifesciencesipreview.com

Photo by Ousa Chea on Unsplash

Top